Keratoconjunctivitis Sicca: all 797 studies

Page 7 of 8. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.

• Effect of Nursing Care on Prevention of Dry EyeStatus unknownNCT02767258Not applicable
• In Vivo Confocal Microscopic Analysis of Corneal Nerve Changes After ProKera Slim® for Dry EyeCompletedNCT02764814Not applicable
• Comparison of Autologous Serum Versus Preservative Free Artificial TearCompletedNCT02752763Phase 4
• Exploring Immune Cell Signatures in Autoimmunity and Dry Eye SyndromeCompletedNCT02715323
• Ocular Surface Disease in Chronic Graft-Versus-Host Disease (GVHD) PatientsCompletedNCT02712762
• Effects of a Moisturizing Product on Dry Eye and SkinCompletedNCT02683382Not applicable
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye DiseaseCompletedNCT02665234Phase 3
• A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT02634853Phase 3
• Feasibility of IPL for Reducing Dry Eye Symptoms Caused by MGDCompletedNCT02621593Not applicable
• Comparison of the Efficacy and Safety of T2762 Versus Optive® in the Treatment of Moderate to Severe Dry Eye SyndromeTerminatedNCT02617095Not applicable
• Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome: ARISE-1CompletedNCT02597803Phase 2/3
• 0.3% Sodium Hyaluronate in the Treatment of Dry Eye of Diabetic PatientsStatus unknownNCT02595606Phase 4
• Added Benefits of Lachrymal Substitute Gel During the Night in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585648Not applicable
• Influence of Lachrymal Substitute Gels on Tear Film Thickness in Patients With Moderate to Severe Dry Eye SyndromeCompletedNCT02585453Phase 4
• A Retrospective Analysis of Restasis® Benefits in Dry Eye Contact Lens PatientsCompletedNCT02522312
• A Phase III Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503189Phase 3
• An Extension Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeTerminatedNCT02503176Phase 3
• A Long-term Study of KCT-0809 in Dry Eye Patients With Sjögren's SyndromeCompletedNCT02503163Phase 3
• Efficacy and Safety of HE10 for Dry Eye SyndromeCompletedNCT02492412Phase 3
• Efficacy and Safety Study of TJCS for Treatment of Moderate to Severe Dry Eye SyndromesCompletedNCT02461719Phase 3
• Three Dimension Tomography of Eye Structures by White Light Imaging DeviceStatus unknownNCT02424266
• Dry Eye Treatment With Artificial TearsCompletedNCT02420834Not applicable
• Safety, Tolerability and Systemic Pharmacokinetics of AGN-232411 in Healthy Participants and Participants With Dry EyeCompletedNCT02420730Phase 1
• Tear Osmolarity Clinical Utility in Dry Eye DiseaseCompletedNCT02417116Not applicable
• Study of EBI-005 in Dry Eye Disease (DED)Status unknownNCT02405039Phase 3
• Paralysis of the Orbicularis Muscle of the Eye in the Treatment for Dry EyeCompletedNCT02403219Phase 1
• The Effect of Eyelid Surgery on Dry Eye - a Prospective StudyCompletedNCT02376556
• Study of ST266 Eye Drops in Treating Dry EyeCompletedNCT02369861Phase 1
• Phase 2 Study With Cis-UCA Ophthalmic Solutions in Subjects With Dry EyeCompletedNCT02326090Phase 2
• Ocular Surface Dry Eye MicrobiomeStatus unknownNCT02306668
• The Influence of PRN Dry Eye Omega-3 Nutritional Regimen on Tear Osmolarity In Cases Of Dry Eye DiseaseCompletedNCT02260960Phase 2/3
• Study of the Safety and Tolerability of P 321 Ophthalmic Solution in Subjects With Dry Eye DiseaseCompletedNCT02242032Phase 1
• Efficacy and Safety of XG-104 for the Treatment of Dry EyeCompletedNCT02235259Phase 2
• Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye DiseaseCompletedNCT02229955Phase 3
• Randomised Research Comparing Acupuncture, Herbal Treatment and Artificial Tear Eye Drops in Dry EyeCompletedNCT02219204Not applicable
• Topical Steroid Treatment For Dry EyeStatus unknownNCT02218827Not applicable
• Dry Eye Evaluation After Transepithelial PRKCompletedNCT02210793Not applicable
• A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry Eye.CompletedNCT02205840Phase 2/3
• Ocular Surface Microbiome in Dry Eye PatientsCompletedNCT02161341
• The Role of Cytokines and Mast Cell in the Pathogenesis of SLK, Conjunctivochalasis, and Dry EyeStatus unknownNCT02160327
• Treating Dry Eyes and Corneal Ulcers With Fingerprick Autologous BloodStatus unknownNCT02153515Phase 3
• Evaluation of Therapeutic Effect of Bandage Contact Lenses ( BCL) on Dry Eye Caused by Sjogren's SyndromeCompletedNCT02147509Not applicable
• A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye SyndromeCompletedNCT02139033Phase 4
• Civamide Nasal Solution for the Treatment of Dry EyeCompletedNCT02116244Phase 2
• Phase 2 Study to Evaluation the Safety and Efficacy of Orally Administered KL7016 in Patients With Dry Eye SyndromeCompletedNCT02092207Phase 2
• Safety and Efficacy of PG101 for Dry Eye SyndromeCompletedNCT02078661Phase 1/2
• Efficacy and Safety of Fluorometholone (FML) in Dry Eye Disease (Keratoconjunctivitis Sicca)CompletedNCT02051023Phase 3
• Ocular Surface Immune Response in Dry Eye DiseaseCompletedNCT02042820
• A Phase IV, Randomized, Parallel Group, Investigator-Masked Evaluation of the Effect of Loteprednol Etabonate Ophthalmic Gel 0.5% on the Initiation of Dry Eye Treatment With Restasis®WithdrawnNCT02028312Phase 4
• A Study to Determine the Relief of Dry Eye Symptoms With the Use of TheraTears® Products (DUNLIN)CompletedNCT02014922Phase 4
• A Randomized, Parallel-Group Comparison Study of Topical Corticosteroids in Dry Eye Patients With Sjögren SyndromeCompletedNCT02011776
• Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseCompletedNCT02004067Phase 4
• Phase 3 Study of EBI-005 in Dry Eye DiseaseCompletedNCT01998802Phase 3
• Dry Eye Symptoms and Quality of LifeCompletedNCT01988597
• A Safety and Efficacy Study of MIM-D3 Ophthalmic Solution for the Treatment of Dry EyeCompletedNCT01960010Phase 3
• Efficacy of Topical 0.2% Xanthan Gum in Patients With Dry EyeCompletedNCT01959854Not applicable
• Pilot Study to Clinical Evaluate Device Prototypes in Dry Eye PatientsWithdrawnNCT01957670Not applicable
• Investigation on Medical Management of Dry Eye PatientsCompletedNCT01942226
• Effect of Contact Lens With Alginic Acid in Dry Eye PatientsCompletedNCT01918410Not applicable
• Efficacy of Pulsed Light Therapy for Meibomian Gland Dysfunction and Dry Eye SyndromeWithdrawnNCT01917539Not applicable
• A Late Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01890941Phase 2
• Dry Eye Disease in the Vitamin D and Omega-3 Trial (VITAL)Status unknownNCT01880463Not applicable
• Influence of Lachrymal Substitutes on Tear Film Thickness in Patients With Moderate Dry Eye SyndromeCompletedNCT01864330Phase 4
• Treatment of Dry Eye Using 0.03% Tacrolimus Eye DropsCompletedNCT01850979Phase 4
• A Phase 1/2, RU-101 Ophthalmic Solution in Patients With Severe Dry EyeCompletedNCT01843894Phase 1/2
• Efficacy and Safety Study of Haporine-S for Treatment of Moderate to Severe Dry Eye SyndromesCompletedNCT01804361Phase 3
• A Study to Evaluate the Performance and Safety of Artelac Rebalance® Versus Vismed in the Management of Dry EyeWithdrawnNCT01791426Not applicable
• Pilot Study to Evaluate SYL1001 Safety and Effect in Patients With Ocular PainCompletedNCT01776658Phase 1/2
• Study of Cyclosporine Ophthalmic Soution Group and Cyclosporine Ophthalmic Suspension GroupCompletedNCT01768312Phase 3
• Evaluation of the Corneal Residence Time of Chitosan-N-acetylcysteine Eye Drops in Patients With Dry Eye Syndrome After Single and Multiple InstillationCompletedNCT01753752Phase 2
• Correlation of Different Signs for Assessment of Dry Eye SyndromeCompletedNCT01753687Not applicable
• Assessment of Tear Film Thickness by Optical Coherence Tomography in Healthy Subjects and Subjects With Dry Eye DiseaseWithdrawnNCT01753596Phase 3
• A Multi-Center Study Subjects With Dry Eye SyndromeCompletedNCT01745887Phase 1
• Reproducibility of Tearfilm Osmolarity Measurements Using TearLab® in Patients With Dry Eye Syndrome and Healthy SubjectsCompletedNCT01744457Not applicable
• Efficacy and Safety of a Treatment for Dry Eye Syndrome: ThealozCompletedNCT01742884Phase 4
• A Safety, Tolerability and Pharmacokinetics Study of R932348 Eye Drops in Patients With Dry Eye DiseaseCompletedNCT01733992Phase 1
• A Parallel Group Phase II Study of KCT-0809 in Patients With Dry Eye SyndromesCompletedNCT01692145Phase 2
• A Study of RX-10045 in the Treatment of Dry Eye DiseaseCompletedNCT01675570Phase 2
• Phase II Study of DA-6034 Eye Drops in Dry Eye SyndromeCompletedNCT01670357Phase 2
• Efficacy and Safety of Rebamipide in Subjects With Dry Eye SyndromeCompletedNCT01632137Phase 3
• The Effect of Intravenous Glucocorticoids on the Tearfilm in Eyes With Thyroid-associated OphthalmopathyCompletedNCT01579539Phase 3
• Efficacy of Nonsteroidal Anti-inflammatory Drugs in Treatment of Moderate and Severe Dry Eye DiseaseCompletedNCT01562795Not applicable
• Oral Nutrition Impact on Tear FilmStatus unknownNCT01561040Phase 4
• A Clinical Study Evaluating the Safety and Efficacy of SI-614 Ophthalmic Solution in Patients With Dry EyeCompletedNCT01558999Phase 2
• Effect of Controlled Adverse Environment (CAE) on Tear Film StabilityCompletedNCT01547936
• Efficacy Study of a New Eyedrop on Silicone Hydrogel Contact Lens Wearers With Dry Eye ComplaintsCompletedNCT01543061Phase 4
• The Effect of Hinge Location on Corneal Sensation and Dry Eye After LASIK: A Systematic Review and Meta-analysisCompletedNCT01507025
• Comparison of Evaporimetry With the Established Methods of Tear Film MeasurementCompletedNCT01496482
• In Vivo Measurement of Corneal Epithelial Changes in Dry Eye PatientsCompletedNCT01483989Not applicable
• A Dose-Finding Study Comparing InSite Vision, Inc. 101 to Vehicle and DuraSite Alone for Dry Eye DiseaseWithdrawnNCT01478555Phase 2
• A Study Assessing the Safety and Efficacy of DE-101 Ophthalmic Suspension in Dry Eye PatientsCompletedNCT01468168Phase 2
• Corneal Sensation and Incidence of Dry Eye Post Refractive Cataract Extraction With FemtoSecond LaserStatus unknownNCT01441895
• Safety Evaluation of a New Preservative in a Lubricating Eye DropCompletedNCT01434277Not applicable
• A Phase II Study of KCT-0809 in Patients With Dry Eye SyndromeCompletedNCT01427816Phase 2
• Moisture Chamber Glasses for Dry Eye in Asian PopulationCompletedNCT01388426Not applicable
• Efficacy of FreshKote and Systane for the Treatment of Dry Eye and Improvement of OsmolarityStatus unknownNCT01386073Phase 4
• Efficacy of the Chronic Application of Tear FormulationsStatus unknownNCT01384851Not applicable
• Altaire Gel Forming Solution Versus Refresh Tears for the Treatment of Dry Eye Signs and SymptomsStatus unknownNCT01382810Phase 4
• Treatment of Dry Eye With SupplementsWithdrawnNCT01364311Not applicable
• Sodium Hyaluronate and Wavefront Aberrations in Dry EyesCompletedNCT01363414Not applicable

← Keratoconjunctivitis Sicca overview